Los puntos clave no están disponibles para este artículo en este momento.
Posaconazole was similar to fluconazole for prophylaxis against fungal infections among patients with GVHD. It was superior in preventing invasive aspergillosis and reducing the rate of deaths related to fungal infections. (ClinicalTrials.gov number, NCT00034645 ClinicalTrials.gov.).
Ullmann et al. (Thu,) studied this question.